GI
DXCM icon

Gradient Investments’s DexCom DXCM Stock Holding History

Gradient Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1M Buy
372,542
+53,283
+17% +$3.55M 0.35% 90
2026
Q1 		$20M Sell
319,259
-12,747
-4% -$888K 0.31% 98
2025
Q4 		$22M Buy
332,006
+40,343
+14% +$2.61M 0.35% 88
2025
Q3 		$19.6M Buy
291,663
+21,915
+8% +$1.73M 0.33% 95
2025
Q2 		$23.5M Sell
269,748
-11,577
-4% -$907K 0.43% 79
2025
Q1 		$19.2M Buy
281,325
+26,782
+11% +$2.19M 0.39% 82
2024
Q4 		$19.8M Buy
254,543
+58,947
+30% +$4.36M 0.4% 73
2024
Q3 		$13.1M Buy
195,596
+27,657
+16% +$2.27M 0.27% 115
2024
Q2 		$19M Buy
167,939
+8,098
+5% +$1.02M 0.43% 71
2024
Q1 		$22.2M Buy
159,841
+7,002
+5% +$880K 0.51% 54
2023
Q4 		$19M Buy
152,839
+33,742
+28% +$3.45M 0.46% 62
2023
Q3 		$11.1M Buy
119,097
+10,596
+10% +$1.19M 0.29% 112
2023
Q2 		$13.9M Buy
108,501
+6,091
+6% +$737K 0.36% 99
2023
Q1 		$11.9M Buy
102,410
+13,584
+15% +$1.52M 0.32% 102
2022
Q4 		$10.1M Sell
88,826
-14,485
-14% -$1.59M 0.32% 104
2022
Q3 		$8.32M Sell
103,311
-28,137
-21% -$2.38M 0.25% 114
2022
Q2 		$9.8M Buy
131,448
+8,992
+7% +$821K 0.29% 103
2022
Q1 		$15.7M Buy
122,456
+16,572
+16% +$1.81M 0.4% 57
2021
Q4 		$14.2M Buy
105,884
+17,336
+20% +$2.49M 0.36% 67
2021
Q3 		$12.1M Sell
88,548
-2,864
-3% -$361K 0.34% 77
2021
Q2 		$9.76M Buy
91,412
+9,336
+11% +$897K 0.29% 106
2021
Q1 		$7.37M Buy
82,076
+81,408
+12,187% +$7.64M 0.24% 116
2020
Q4 		$69K Hold
668
– – ﹤0.01% 357
2020
Q3 		$69K Hold
668
– – ﹤0.01% 360
2020
Q2 		$68K Hold
668
– – ﹤0.01% 342
2020
Q1 		$45K Hold
668
– – ﹤0.01% 360
2019
Q4 		$37K Hold
668
– – ﹤0.01% 456
2019
Q3 		$25K Hold
668
– – ﹤0.01% 493
2019
Q2 		$25K Buy
+668
New +$21K ﹤0.01% 480

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Gradient Investments's DXCM Position: Q2 2026 in Review

Gradient Investments increased its DexCom (DXCM) stake by 17% in Q2 2026, buying an estimated $3.55M and bringing the position to 372,542 shares worth $25.1M. The position accounts for 0.35% of the portfolio, ranked #90.

Gradient Investments first reported a position in DXCM in Q2 2019 and has held it in 29 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Gradient Investments held 372,542 shares of DexCom worth $25.1M as of Q2 2026.
  • Gradient Investments bought 53,283 DexCom shares in Q2 2026, an estimated $3.55M.
  • DexCom made up 0.35% of Gradient Investments's portfolio in Q2 2026, its #90 holding.
  • Gradient Investments first reported a position in DexCom in Q2 2019 and has held it in 29 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.